Buchbeiträge: 

1.    Reinartz P. Pulmonary Function - Methods in Nuclear Medicine. In: Encyclopedic Reference of Imaging. Baert AL. Berlin, Heidelberg, New York: Springer Verlag 2008; 1546-1549.

2.    Reinartz P, Sabri O. Lunge. In: Nuklearmedizin. Kuwert T, Haberkorn U, Bartenstein P, Behr TM, Krause TM. Stuttgart, New York: Georg Thieme Verlag 2008; 258-271.

3.    Büll U, Bares R, Reinartz P. Nuklearmedizinische Diagnostik und Therapie. In: Praxis der konservativen Orthopädie. Bischoff HP, Heisel J, Locher H. Stuttgart, New York: Georg Thieme Verlag 2007; 60-77.

 

Originalarbeiten:

1.    Reinartz P, FDG-PET in patients with painful hip and knee arthroplasty: technical breakthrough or just more of the same. Q J Nucl Med Mol Imaging 2009; 53: 41-50.

2.    Mahnken AH, Bruners P, Stanzel S, Koos R, Mühlenbruch G, Günther RW, Reinartz P, Functional imaging in the assessment of myocardial infarction: MR imaging vs. MDCT vs. SPECT. Eur J Radiol 2009; 71: 480-485.

3.    Reinartz P, To PIOPED, or not to PIOPED. J Nucl Med 2008; 49: 1739-1740.

4.    Gagel B, Piroth M, Pinkawa M, Reinartz P, Zimny M, Kaiser HJ, Stanzel S, Asadpour B, Demirel C, Hamacher K, Coenen HH, Scholbach T, Maneschi P, DiMartino E, Eble MJ. pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia? BMC Cancer 2007; 7: 113.

5.    Gagel B, Piroth M, Pinkawa M, Reinartz P, Krohn T, Kaiser HJ, Stanzel S, Breuer C, Asadpour B, Schmachtenberg A, Eble MJ. Sequential (gemcita- bine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study. BMC Cancer 2007; 7:112.

6.    Nowak B, Weber C, Schober A, Zeiffer U, Liehn EA, von Hundelshausen P, Reinartz P, Schaefer WM, Buell U. 111Indium-oxine labelling affects cellular integrity of hematopoietic progenitor cells. Eur J Nucl Med Mol Imaging 2007; 34: 715-721.

7.    Zimny M, Gagel B, DiMartino E, Hamacher K, Coenen H, Westhofen M, Eble M, Buell U, Reinartz P. FDG - a marker of tumour hypoxia? A comparison with [18F]-fluoromisonidazole and pO2-polarography in metastatic head and neck cancer. Eur J Nucl Med Mol Imaging 2006; 33: 1426-1431.

8.    Gagel B, Piroth M, Pinkawa M, Reinartz P, Zimny M, Fischedik K, Stanzel S, Breuer C, Skobel E, Asadpour B, Schmachtenberg A, Buell U, Eble MJ. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with Gemcitabine/Vinorelbine in locally advanced non-small cell lung cancer. A phase I study. Strahlenther Onkol 2006; 182: 263-269.

9.    Reinartz P, Kaiser HJ, Wildberger JE, Gordji C, Nowak B, Buell U. SPECT imaging in the diagnosis of pulmonary embolism: automated detection of match and mismatch defects by means of image processing techniques.
J Nucl Med 2006; 47: 968-973.

10.    Gagel B, Reinartz P, Demirel C, Kaiser HJ, Zimny M, Piroth M, Pinkawa M, Stanzel S, Asadpour B, Hamacher K, Coenen HH, Buell U, Eble MJ.
18F-fluoromisonidazole and 18F-fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study. BMC Cancer 2006; 6: 51.

11.    Mumme T, Reinartz P, Alfer J, Müller-Rath R, Buell U, Wirtz DC. Diagnostic values of positron emission tomography versus triple-phase bone scan in hip arthroplasty loosening. Arch Orthop Trauma Surg 2005; 125: 322-329.

12.    Reinartz P, Mumme T, Hermanns B, Cremerius U, Wirtz DC, Schaefer WM, Niethard F-U, Buell U. Radionuclide imaging of the painful hip arthroplasty: positron emission tomography versus triple-phase bone scan. J Bone Joint Surg [Br] 2005; 87: 465-470.

13.    Buell U, Wieres FJ, Schneider W, Reinartz P. 18FDG-PET in 733 consecutive patients with or without side-by-side CT evaluation: Analysis of 921 lesions. Nuklearmedizin 2004; 43: 210-216.

14.    Schaefer WM, Lipke CSA, Kühl HP, Koch KC, Kaiser HJ, Reinartz P, Nowak B, Buell U. Prone versus supine patient positioning during gated 99mTc-sestamibi SPECT: Effect on left ventricular volumes, ejection fraction, and heart rate. J Nucl Med 2004; 2016-2020.

15.    Gagel B, Reinartz P, DiMartino E, Zimny M, Pinkawa M, Maneschi P, Stanzel S, Hamacher K, Coenen HH, Westhofen M, Büll U, Eble MJ. pO2 polarography versus positron emission tomography ([18F] fluoromiso-nidazole, [18F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia. Strahlenther Onkol 2004; 180: 616-622.

16.    Reinartz P, Wieres FJ, Schneider W, Schur A, Buell U. Side-by-side reading of PET and CT scans in oncology: Which patients might profit from integrated PET/CT? Eur J Nucl Med Mol Imaging 2004; 31: 1456-1461.

17.    Reinartz P, Wildberger JE, Schaefer W, Nowak B, Mahnken AH, Buell U. Tomographic imaging in the diagnosis of pulmonary embolism: a comparison between V/Q lung scintigraphy in SPECT technique and multislice spiral CT. J Nucl Med 2004; 45: 1501-1508.

18.    Nowak B, Stellbrink C, Schaefer WM, Sinha AM, Breithardt OA, Kaiser HJ, Reinartz P, Hanrath P, Buell U. Comparison of regional myocardial blood flow and perfusion in dilated cardiomyopathie and left bundle branch block: role of wall thickening. J Nucl Med 2004; 45: 414-418.

19.    Schaefer WM, Lipke CSA, Nowak B, Kaiser HJ, Reinartz P, Buecker A, Krombach GA, Buell U, Kuehl HP. Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI. J Nucl Med 2004; 45: 74-79.

20.    Lipke CSA, Kuehl HP, Nowak B, Kaiser HJ, Reinartz P, Koch KC, Buell U, Schaefer WM. Validation of 4D-MSPECT and QGS for quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPET: comparison with cardiac magnetic resonance imaging. Eur J Nucl Med Mol Imaging 2004; 31: 482-490.

21.    Nowak B, Stellbrink C, Sinha AM, Kaiser HJ, Reinartz P, Koos R, Markus K, Hanrath P, Buell U, Schaefer WM. Effects of cardiac resynchronization therapy on myocardial blood flow measured by oxygen-15 water positron emission tomography in idiopathic dilated cardiomyopathie and left bundle branch block. Am J Cardiol 2004; 93: 496-499.

22.    Reinartz P, Zimny M, Schaefer W, Mueller B, Buell U, Sabri O. Radioiodine therapy in patients with hyperthyroid disorder: standard versus dosimetric activity application. Nucl Med Commun 2003; 24: 1247-1253.

23.    Geier A, Gartung C, Dietrich CG, Wasmuth HE, Reinartz P, Matern S. Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: effect of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC. World J Gastroentrerol 2003; 9: 2681-2685.

24.    Mumme T, Reinartz P, Cremerius U, Hermanns B, Müller-Rath R,
Neuss M, Büll U, Wirtz DC. Die [F-18]-Fluorodeoxyglucose (FDG) Positronenemissionstomographie (PET) als Differenzialdiagnostikum der Hüftendoprothesenlockerung. Z Orthop 2003; 141: 540-546.

25.    Cremerius U, Mumme T, Reinartz P, Wirtz D, Niethard FU, Büll U. Analyse des 18F-FDG Speichermusters in der PET zur Diagnostik von septischer und aseptischer Lockerung bei Totalendoprothesen des Hüftgelenks. Nuklearmedizin 2003; 42: 234-239.

26.    Zimny M, Hochstenbag M, Lamers R, Reinartz P, Cremerius U, ten Velde G, Buell U. Mediastinal staging of lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography and a dual-head coincidence gamma camera. Eur Radiol 2003; 13: 740-747.

27.    Schaefer WM, Koch KC, Kuhl HP, Reinartz P, Kaiser HJ, vom Dahl J, Sabri O, Buell U, Nowak B. Effects of left ventricular volume and ejection on myocardial blood flow measured by oxygen-15 water positron emission tomography in coronary heart disease. Am J Cardiol 2003; 91: 469-472.

28.    Reinartz P, Sabri O, Zimny M, Nowak B, Cremerius U, Setani K, Büll U. Thyroid volume measurement in patients prior to radioiodine therapy: comparison between three-dimensional magnetic resonance imaging and ultrasonography. Thyroid 2002; 8: 713-717.

29.    Cremerius U, Fabry U, Wildberger JE, Simony M, Reinartz P, Nowak B, Schäfer W, Büll U, Osieka R. Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin´s lymphoma. Bone Marrow Transplant 2002; 30: 103-111.

30.    Reinartz P, Schirp U, Zimny M, Sabri O, Nowak B, Cremerius U, Büll U. Optimizing ventilation-perfusion lung scintigraphy: parting with planar imaging. Nuklearmedizin 2001; 40: 38-43.

31.    Sabri O, Zimny M, Schreckenberger M, Reinartz P, Nowak B, Ostwald E, Schäfer W, Block S, Setani K, Büll U. Charakterisierung von Therapieversagern bei der Radioiodtherapie des Morbus Basedow ohne simultane Thyreostase. Nuklearmedizin 2001; 40: 1-6.

32.    Sabri O, Zimny M, Schreckenberger M, Meyer-Oelmann A, Reinartz P, Buell U. Does thyroid stunning exist? A model with benign thyroid disease. Eur J Nucl Med 2000; 27: 1591-1597.

33.    Nowak B, Zimny M, Schwarz ER, Kaiser HJ, Schaefer W, Reinartz P, vom Dahl J, Buell U. Diagnosis of myocardial viability by dual-head coincidence gamma camera fluorine-18 fluorodeoxyglucose positron emission tomography with and without non-uniform attenuation correction. Eur J Nucl Med 2000; 27: 1501-1508.

34.    Reinartz P, Schaffeldt J, Sabri O, Zimny M, Nowak B, Ostwald E, Cremerius U, Büll U. Benign versus malignant osseous lesions in the lumbar vetebrae: differentiation by means of bone SPET. Eur J Nucl Med 2000; 27: 721-726.

35.    Sabri O, Hellwig D, Schreckenberger M, Schneider R, Kaiser H-J, Wagenknecht G, Setani K, Reinartz P, Zimny M, Mull M, Ringelstein E-B, Büll U. One-year follow-up of neuropsychology, MRI, rCBF and glucose metabolism (rMRGLu) in cerebral microangiopathy. Nuklearmedizin 2000; 39: 43-49.

36.    Franke J, Rosenzweig S, Reinartz P, Höer J, Kasperk R, Schumpelick V. Die Wertigkeit der Positronen-Emissionstomographie (18F-FDG-PET) in der Diagnostik von Rectum-Rezidivcarzinomen. Chirurg 2000; 71: 80-85.

37.    Zimny M, Kaiser H-J, Cremerius U, Reinartz P, Schreckenberger M, Sabri O, Büll U. Dual-head gamma camera 2-[fluorine-18]fluoro2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection. Eur J Nucl Med 1999; 26: 818-823.

38.    Sabri O, Zimny M, Schulz G, Schreckenberger M, Reinartz P, Willmes K, U. Büll. Success rate of radioiodine therapy in Graves´ Disease: the influence of thyrostatic medication. J Clin Endocrinol Metab 1999; 84: 1229-1333.

39.    Nowak B, Di Martino E, Jänicke S, Cremerius U, Adam G, Zimny M, Reinartz P, Büll U. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI. Nuklearmedizin 1999; 38: 312-318.

40.    Reinartz P, Zimny M, Cremerius U, Sabri O, Kaiser H-J, Nowak B, Büll U. Quantifizierung von Repositionierungsfehlern bei PET-Studien durch Überlagerung von Emissions- und Transmissionsscan. Nuklearmedizin 1999; 38: 192-198.

41.    Zimny M, Kaiser H-J, Cremerius U, Sabri O, Schreckenberger M, Reinartz P, Büll U. F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET. Nuklearmedizin 1999; 38: 108-114.

42.    Sabri O, Zimny M, Schreckenberger M, Reinartz P, Ostwald E, Büll U. Radioiodine therapy in Graves´ disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy. Thyroid 1999; 9: 1181-1888.

43.    Schmitz F-J, Küppers B, Reinartz P, Vossel R, Schuppe HC, Bielfeld P, Somville T, Heinz HP. Vergleich verschiedener Methoden zur Detektion von Chlamydia trachomatis in zervikalen und urethralen Abstrichen verschiedener Patientenkollektive. Clin Lab 1996; 42: 1059-1067.

 

Kasuistiken:

1.    Kisielinski K, Reinartz P, Mumme T, Büll U. Die FDG-PET stellt Fremdkörperreaktionen gegen Polyethylen-Abriebpartikel in nicht infizierten Knieendoprothesen dar. Nuklearmedizin 2004; 43: N3-N6.

2.    Kisielinski K, Cremerius U, Reinartz P, Niethard FU. Fluordeoxyglucose positron emission tomography detection of inflammatory reactions due to polyethylene wear in total hip arthroplasty. J Arthroplasty 2003; 18: 528-532.

3.    Setani K, Habermeyer B, Reinartz P, Kosinski Ch. Verdacht auf Demenz vom Lewy-Körperchen-Typ: Diagnostik mit 18F-FDG-PET, 123I-IBZM und
123I-FP-CIT. Nuklearmedizin 2003; 42: N56-N59.

4.    Reinartz P, Wildberger JE, Büll U. Lungenemboliediagnostik bei kongenitalen Fehlbildungen des Herz-Kreislauf-Systems. Nuklearmedizin 2003; 42: N59-N61.

5.    Nowak B, Sabri O, Hoff C, Reinartz P, Kleinhans E, Zimny M. Unterschiedliche Dynamik von Tc-99m-Tetrofosmin und Tc-99m-MIBI in einem Nebenschilddrüsenadenom. Nuklearmedizin 1999; 38: 160-163.

6.    Reinartz P, Sabri O, Kinzel S, Zimny M, Bachmann T, Küpper W, Büll U.
Die Radioiodtherapie in der Veterinärmedizin: Behandlung der Schilddrüsenüberfunktion bei einer Katze. Nuklearmedizin 1999; 38: 31-34.

 

Editorials:

1.    Reinartz P. To PIOPED or not to PIOPED. J Nucl Med 2008; im Druck.

2.    Büll U, Reinartz P. Quantifizierung in der Skelettszintigraphie mit Tc-99m-Phosphonaten: Determinanten und Bezugspunkte. Nuklearmedizin 2000; 39: N69-N71.

 

 

Briefe:

1.    De Geeter FW, Reinartz P, Büll U. Tomographic imaging in the diagnosis of pulmonary embolism: still, we do not know. J Nucl Med 2005; 46: 2119-2121.

2.    Reinartz P, Nowak B, Weiss C, Buell U. Thin-collimation multi-detector row spiral CT and planar ventilation-perfusion scintigraphy in the diagnosis of acute pulmonary embolism. Radiology 2004; 232: 621.

 

Übersichtsarbeiten:

1.    Reinartz P, Büll U. Pulmonary embolism from a nuclear medicine perspective. Controversies and Consensus in Imaging and Intervention. 2005; 3: 9-12.

2.    Reinartz P, Büll U. Relevanz und Indikationen der Skelettszintigraphie - eine Standortbestimmung. Der Nuklearmediziner 2002; 25: 225-229.